Jacobs Levy Equity Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-587,164
| Closed | -$1.47M | – | 1126 |
|
|
2021
Q4 | $1.47M | Buy |
+587,164
| New | +$1.47M | 0.01% | 676 |
|
|
2021
Q3 | – | Sell |
-156,890
| Closed | -$1.3M | – | 1162 |
|
|
2021
Q2 | $1.3M | Buy |
+156,890
| New | +$1.3M | 0.01% | 691 |
|
|
2019
Q2 | – | Sell |
-35,050
| Closed | -$434K | – | 1059 |
|
|
2019
Q1 | $434K | Sell |
35,050
-73,325
| -68% | -$908K | 0.01% | 797 |
|
|
2018
Q4 | $668K | Buy |
108,375
+18,000
| +20% | +$111K | 0.01% | 685 |
|
|
2018
Q3 | $958K | Buy |
90,375
+18,825
| +26% | +$200K | 0.01% | 654 |
|
|
2018
Q2 | $970K | Buy |
71,550
+25,300
| +55% | +$343K | 0.02% | 670 |
|
|
2018
Q1 | $821K | Buy |
46,250
+1,260
| +3% | +$22.4K | 0.01% | 678 |
|
|
2017
Q4 | $565K | Buy |
44,990
+31,600
| +236% | +$397K | 0.01% | 726 |
|
|
2017
Q3 | $255K | Buy |
+13,390
| New | +$255K | 0.01% | 818 |
|
|
2016
Q4 | – | Sell |
-22,400
| Closed | -$220K | – | 1088 |
|
|
2016
Q3 | $220K | Sell |
22,400
-15,800
| -41% | -$155K | ﹤0.01% | 885 |
|
|
2016
Q2 | $391K | Buy |
+38,200
| New | +$391K | 0.01% | 821 |
|